These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 32061861)
21. The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria. Pillar CM; Stoneburner A; Shinabarger DL; Krause KM; Nichols WW Lett Appl Microbiol; 2016 Aug; 63(2):96-102. PubMed ID: 27221329 [TBL] [Abstract][Full Text] [Related]
22. In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016. Galani I; Souli M; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Antoniadou A; Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1143-1150. PubMed ID: 30825054 [TBL] [Abstract][Full Text] [Related]
23. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055 [TBL] [Abstract][Full Text] [Related]
24. Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases. Joshi P; Shrivastava R; Bhagwat S; Patel M Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115481. PubMed ID: 34332307 [TBL] [Abstract][Full Text] [Related]
25. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt. Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596 [TBL] [Abstract][Full Text] [Related]
26. Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014. Hackel M; Kazmierczak KM; Hoban DJ; Biedenbach DJ; Bouchillon SK; de Jonge BL; Stone GG Antimicrob Agents Chemother; 2016 Aug; 60(8):4677-83. PubMed ID: 27216054 [TBL] [Abstract][Full Text] [Related]
27. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252 [TBL] [Abstract][Full Text] [Related]
28. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014. Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635 [TBL] [Abstract][Full Text] [Related]
29. Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains. Castanheira M; Mills JC; Costello SE; Jones RN; Sader HS Antimicrob Agents Chemother; 2015; 59(6):3509-17. PubMed ID: 25845862 [TBL] [Abstract][Full Text] [Related]
30. Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers. Crandon JL; Nicolau DP Antimicrob Agents Chemother; 2013 Jul; 57(7):3299-306. PubMed ID: 23650162 [TBL] [Abstract][Full Text] [Related]
31. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance. López-Hernández I; Alonso N; Fernández-Martínez M; Zamorano L; Rivera A; Oliver A; Conejo MC; Martínez-Martínez L; Navarro F; Pascual A Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):499-504. PubMed ID: 27887765 [TBL] [Abstract][Full Text] [Related]
32. Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3. Humphries RM; Hemarajata P Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396547 [No Abstract] [Full Text] [Related]
33. Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates. Sader HS; Mendes RE; Pfaller MA; Shortridge D; Flamm RK; Castanheira M Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061754 [TBL] [Abstract][Full Text] [Related]
34. First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate. Humphries RM; Yang S; Hemarajata P; Ward KW; Hindler JA; Miller SA; Gregson A Antimicrob Agents Chemother; 2015 Oct; 59(10):6605-7. PubMed ID: 26195508 [TBL] [Abstract][Full Text] [Related]
35. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015. Sader HS; Castanheira M; Flamm RK Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649 [TBL] [Abstract][Full Text] [Related]
36. In vitro activity of aztreonam-avibactam against metallo-β-lactamase-producing Enterobacteriaceae-A multicenter study in China. Zhang B; Zhu Z; Jia W; Qu F; Huang B; Shan B; Yu H; Tang Y; Chen L; Du H Int J Infect Dis; 2020 Aug; 97():11-18. PubMed ID: 32473388 [TBL] [Abstract][Full Text] [Related]
37. Activity of ceftaroline-avibactam tested against contemporary Enterobacteriaceae isolates carrying β-lactamases prevalent in the United States. Castanheira M; Williams G; Jones RN; Sader HS Microb Drug Resist; 2014 Oct; 20(5):436-40. PubMed ID: 24593056 [TBL] [Abstract][Full Text] [Related]
38. The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against β-lactamase-producing Enterobacteriaceae studied in an in vitro model of infection. MacGowan A; Tomaselli S; Noel A; Bowker K J Antimicrob Chemother; 2017 Mar; 72(3):762-769. PubMed ID: 28039276 [TBL] [Abstract][Full Text] [Related]
39. Meropenem-Vaborbactam Resistance Selection, Resistance Prevention, and Molecular Mechanisms in Mutants of KPC-Producing Klebsiella pneumoniae. Sun D; Rubio-Aparicio D; Nelson K; Dudley MN; Lomovskaya O Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 29038260 [TBL] [Abstract][Full Text] [Related]
40. In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase. Livermore DM; Warner M; Jamrozy D; Mushtaq S; Nichols WW; Mustafa N; Woodford N Antimicrob Agents Chemother; 2015 Sep; 59(9):5324-30. PubMed ID: 26100712 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]